Trials / Completed
CompletedNCT01431820
Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis
Safety and Efficacy of Luliconazole Solution, 10% With Two Dosing Regimens in Distal Subungual Onychomycosis of the Toenails: A Randomized, Double-Blind, Vehicle-Controlled, Phase 2B/3 Study
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 334 (actual)
- Sponsor
- Topica Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety and efficacy of a topical antifungal formulation, Luliconazole Solution, 10%, in the treatment of adults with onychomycosis of the toenails.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Luliconazole Solution, 10% | Topical |
| DRUG | Vehicle Solution | Topical |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2014-06-01
- Completion
- 2014-08-01
- First posted
- 2011-09-12
- Last updated
- 2015-11-30
Locations
28 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01431820. Inclusion in this directory is not an endorsement.